Propane, shattered glass, and parasites

doi:10.1017/9781108623872.003

Case 3: - Propane, shattered glass, and parasites

Published online by Cambridge University Press: 03 April 2024

Charles Welch

Edited by

Nevena V. Radonjić ,

Thomas L. Schwartz and

Stephen M. Stahl

Show author details

Nevena V. Radonjić: Affiliation:
State University of New York Upstate Medical University
Thomas L. Schwartz: Affiliation:
State University of New York Upstate Medical University
Stephen M. Stahl: Affiliation:
University of California, San Diego

Book contents

Get access

Summary

Some atypical antipsychotics exert their antipsychotic and antidepressant effects via partial agonism of the dopamine-2 receptor (D2). The inhibition of which hepatic cytochrome P450 (CYP450) enzyme would have the most prominent effect on a patient’s serum concentration of this class of atypical antipsychotic drugs (sometimes called the PIPS and the RIPS …)?

Keywords

psychosis schizophrenia risperidone (Risperdal)aripiprazole (Abilify)

Type: Chapter
Information: Case Studies: Stahl's Essential Psychopharmacology , pp. 39 - 52

DOI: https://doi.org/10.1017/9781108623872.003 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Subscription

Individual access

Subscriptions are only available for individuals and not institutional access. Subscribe now

References

Bak, M, Fransen, A, Janssen, J, et al. Almost all antipsychotics result in weight gain: a meta-analysis. PLoS One 2014; 9:e94112CrossRef Google Scholar PubMed

Cochran, JM, Fang, H, Le Gallo, C, et al. Participant engagement and symptom improvement: aripiprazole tablets with sensor for the treatment of schizophrenia. Patient Prefer Adherence 2022; 16:1805–17CrossRef Google Scholar PubMed

Doane, MJ, Bessonova, L, Friedler, HS, et al. Weight gain and comorbidities associated with oral second-generation antipsychotics: analysis of real-world data for patients with schizophrenia or bipolar I disorder. BMC Psychiatry 2022; 22:114CrossRef Google Scholar PubMed

Higashi, K, Medic, G, Littlewood, KJ, et al. Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Ther Adv Psychopharmacol 2013; 3:200–18CrossRef Google Scholar PubMed

Lian, L, Kim, DD, Procyshyn, RM, et al. Long-acting injectable antipsychotics for early psychosis: a comprehensive systematic review. PLoS One 2022; 17:e0267808CrossRef Google Scholar PubMed

Reymann, S, Schoretsanitis, G, Egger, ST, et al. Use of long-acting injectable antipsychotics in inpatients with schizophrenia spectrum disorder in an academic psychiatric hospital in Switzerland. J Pers Med 2022; 12:441CrossRef Google Scholar

Stahl, SM. Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 5. Cambridge: Cambridge University Press, 2021CrossRef Google Scholar